The Colossal Problem of Publicly Funded Vaccines in Private Hands

The biotech company Moderna injected a new dose of optimism into the fight against COVID-19 on Monday by announcing that its vaccine candidate had shown a success rate of 94.5% in clinical trials .The announcement, however, raises new questions about how a successful vaccine will be distributed to the public — how fast, how broadly and at what price?

Source: The Colossal Problem of Publicly Funded Vaccines in Private Hands | Portside

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s